InvestorsHub Logo
Post# of 253225
Next 10
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

Re: DewDiligence post# 163767

Wednesday, 07/10/2013 10:03:39 AM

Wednesday, July 10, 2013 10:03:39 AM

Post# of 253225
I've never implicitly handicapped the three trials. I merely pointed out that, of the 3 trials, Eyeguard B is the only one with Ph2 results which introduces an additional risk factor to the investment decision. For the record, I agree with your and iwfal's assessment.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.